Bringing together leading omics experts from around the world and comprised of three outstanding programmes, delegates can expect to benefit from critical discussions in the future of Next Generation Sequencing, Multi-omic Single Cell and Spatial Analyses and Genome editing in Drug Discovery and Therapeutic Development.
Discover collaborative solutions to clinical genomics and diagnostics. Presentations will cover applications of NGS & transformational technologies in regenerative medicine, pathology informatics, and computational approaches for multiomic data integration.
Discuss the latest innovations in spatial research & technologies. Hear in-depth presentations on spatial transcriptomic profiling, spatial proteomics in drug development, and spatial analytics for tumor microenvironment.
Join thought-leaders in the single cell landscape to learn about current & emerging tools and clinical applications of single cell analyses, and to have a unique opportunity to discuss the pressing challenges & priorities going forward.
Explore novel developments in genome editing tools & techniques such as base-editors, and learn how researchers are using genome editing to identify drug targets, treat monogenic diseases, and more.
Discover collaborative solutions to clinical genomics and diagnostics. Presentations will cover applications of NGS & transformational technologies in regenerative medicine, pathology informatics, and computational approaches for multiomic data integration.
Discuss the latest innovations in spatial research & technologies. Hear in-depth presentations on spatial transcriptomic profiling, spatial proteomics in drug development, and spatial analytics for tumor microenvironment.
Join thought-leaders in the single cell landscape to learn about current & emerging tools and clinical applications of single cell analyses, and to have a unique opportunity to discuss the pressing challenges & priorities going forward.
Explore novel developments in genome editing tools & techniques such as base-editors, and learn how researchers are using genome editing to identify drug targets, treat monogenic diseases, and more.
